| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Cost of products sold, excluding depreciation and amortization and other items | |||||||||||
1,215 | 1,300 | 1,085 | 1,000 | 1,115 | 1,117 | 1,038 | 1,116 | 1,129 | 946 | 766 | 1,400 |
Revenue from Contract with Customer, Excluding Assessed Tax | |||||||||||
1,514 | 1,585 | 1,397 | 1,330 | 1,391 | 1,356 | 1,297 | 1,360 | 1,301 | 1,079 | 987 | 1,508 |
Costs and expenses: | |||||||||||
Lower of cost or market inventory write-down | |||||||||||
- | - | - | 4 | 2 | 0 | 0 | - | - | - | 9 | 65 |
Unrealized (gain) loss on derivative instruments | |||||||||||
- | - | - | - | -3 | -10 | 0 | 15 | -29 | -0 | - | - |
Impairment of investment in Anglesey | |||||||||||
- | - | - | - | - | - | - | - | - | - | 1 | 37 |
Restructuring benefits | |||||||||||
- | - | - | - | - | - | - | - | -0 | -0 | 5 | 8 |
Depreciation and amortization | |||||||||||
49 | 43 | 39 | 36 | 32 | 31 | 28 | 26 | 25 | 19 | 16 | 14 |
Selling, general, administrative, research and development | |||||||||||
98 | 96 | 97 | 105 | 88 | 81 | 80 | 74 | 62 | 67 | 69 | 73 |
Net periodic postretirement benefit cost relating to Salaried VEBA | |||||||||||
- | - | - | - | 2 | -23 | -22 | - | - | - | - | - |
(Gain) loss on removal of Union VEBA net assets Note 4 | |||||||||||
- | - | - | - | 493 | 0 | 0 | - | - | - | - | - |
Defined benefit plan, net periodic benefit cost - VEBAs | |||||||||||
- | - | - | - | - | - | - | -11 | - | - | - | - |
Total selling, general, administrative, research and development | |||||||||||
- | - | - | - | 583 | 57 | 57 | 62 | - | - | - | - |
Goodwill, Impairment Loss | |||||||||||
25 | 0 | 18 | 0 | 0 | - | - | - | - | - | - | - |
Other operating charges, net | |||||||||||
-0 | -1 | -0 | -2 | -0 | -1 | 0 | -4 | 0 | -4 | -0 | -1 |
Total costs and expenses | |||||||||||
1,388 | 1,442 | 1,242 | 1,149 | 1,737 | 1,218 | 1,124 | 1,194 | 1,246 | 1,038 | 868 | 1,599 |
Operating income | |||||||||||
125 | 143 | 155 | 181 | -345 | 137 | 173 | 165 | 55 | 41 | 118 | -91 |
Other (expense) income: | |||||||||||
Interest expense | |||||||||||
-24 | -22 | -22 | -20 | -24 | -37 | -35 | -29 | -18 | 11 | 0 | 1 |
Other Nonoperating Income (Expense) | |||||||||||
-20 | -0 | 0 | -13 | -1 | 6 | 5 | 2 | 4 | -4 | -0 | 0 |
Income before income taxes | |||||||||||
80 | 120 | 133 | 147 | -371 | 107 | 143 | 139 | 41 | 25 | 118 | -91 |
Income Tax Expense (Benefit) | |||||||||||
18 | 28 | 87 | 55 | -135 | 35 | 38 | 53 | 16 | 13 | 48 | -22 |
Net Income (Loss) Attributable to Parent | |||||||||||
62 | 91 | 45 | 91 | -236 | 71 | 104 | 85 | 25 | 12 | 70 | -68 |
Net income per common share: | |||||||||||
Basic (in dollars per share) | |||||||||||
3.88 | 5.53 | 2.67 | 5.15 | -13.76 | 4.02 | 5.56 | 4.49 | 1.32 | 0.61 | 3.51 | -3.45 |
Diluted (in dollars per share) | |||||||||||
3.83 | 5.43 | 2.63 | 5.09 | -13.76 | 3.86 | 5.44 | 4.45 | 1.32 | 0.61 | 3.51 | -3.45 |
Weighted Average Number of Shares Outstanding, Diluted [Abstract] | |||||||||||
Basic (shares) | |||||||||||
15 | 16 | 16 | 17 | 17 | 17 | 18 | 19 | 18 | 19 | 19 | 0 |
Weighted Average Number of Shares Outstanding, Diluted | |||||||||||
16 | 16 | 17 | 18 | 17 | 18 | 19 | 19 | 18 | 19 | 19 | 0 |
Dividends declared per common share (in dollars per share) | |||||||||||
2.40 | 2.20 | 2.00 | 1.80 | 1.60 | 1.40 | 1.20 | - | - | - | - | - |